Clinical stage: A significant association was for among FADD upregulation and advanced stage tumours (OR = 1.74, 95% CI = 1.26–2.41, p = 0.001) with no observable heterogeneity (p = 0.44, I2 = 0.0). Here, FADD is linked to neoplasm.